(Q41716913)

7 October 2017

title

Hepatitis C therapy in treatment-naïve patients (English)

1 reference

7 October 2017

McHutchison J

1

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

American Journal of Medicine

7 October 2017

published in

1 reference

7 October 2017

volume

107

1 reference

7 October 2017

issue

6B

1 reference

7 October 2017

page(s)

56S-61S

1 reference

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900384-8

10.1016/S0002-9343(99)00384-8

7 January 2021

Identifiers

DOI

1 reference

7 October 2017

1 reference